home.aspx
 
. https://www.biosimilarsip.com/2019/07/17/what-pharma-companies-must-do-globally-to-benefit-from-canadas-patent-term-extension-framework/
blog article
WHAT PHARMA COMPANIES MUST DO GLOBALLY TO BENEFIT FROM CANADA’S PATENT TERM EXTENSION FRAMEWORK
Canada implemented its patent term extension program, the Certificate of Supplementary Protection (CSP) framework, on September 21, 2017.  The CSP regime is beneficial to qualifying pharmaceutical product developers because it can add up to two additional years of patent protection.  Notably, CSP is not as beneficial as other major jurisdictions, which generally allow up to five years of patent term extension. AYDIN HARSTON READ MORE